Literature DB >> 6715956

Quantitation of spreading factor in human biologic fluids.

M C Shaffer, T P Foley, D W Barnes.   

Abstract

Spreading factor (SF) is a glycoprotein isolated from human plasma or serum that promotes attachment and spreading of a wide variety of mammalian cells in culture. Under appropriate conditions, this factor also affects cell proliferation and differentiation in vitro. An immunoassay employing a previously characterized monoclonal antibody to SF, with purified SF as a reference standard, was utilized to quantitate levels of SF in human plasma, serum, amniotic fluid, and urinary protein. Specific anti-SF monoclonal antibody-binding activities in individual samples of human serum were identical to specific anti-SF monoclonal antibody-binding activities in the plasma samples from which the sera were derived. Specific anti-SF monoclonal antibody-binding activity in plasma from adults, when compared with purified SF reference standards, represented an average of 4 micrograms of SF per mg plasma protein (range, 2.5 to 7 micrograms/mg). Specific anti-SF monoclonal antibody-binding activity in sera from fetal cord blood, infants, children, or adolescents was not significantly different from that of adults. Specific anti-SF monoclonal antibody-binding activities in amniotic fluid samples from pregnancies of 12 to 23 weeks' gestation were within the range observed in sera of adults. Anti-SF monoclonal antibody-binding activity in concentrated urinary protein, when compared with purified SF reference standards, represented a specific activity of 10.9 micrograms of SF per mg protein.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6715956

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  19 in total

1.  Sulfated polysaccharide-directed recruitment of mammalian host proteins: a novel strategy in microbial pathogenesis.

Authors:  T D Duensing; J S Wing; J P van Putten
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

3.  Vitronectin from brain pericytes promotes adult forebrain neurogenesis by stimulating CNTF.

Authors:  Cuihong Jia; Matthew P Keasey; Hannah M Malone; Chiharu Lovins; Richard R Sante; Vlad Razskazovskiy; Theo Hagg
Journal:  Exp Neurol       Date:  2018-11-06       Impact factor: 5.330

Review 4.  Evidence for an extra-cellular function for protein kinase A.

Authors:  S Shaltiel; I Schvartz; B Korc-Grodzicki; T Kreizman
Journal:  Mol Cell Biochem       Date:  1993-11       Impact factor: 3.396

5.  Quantitation of vitronectin in serum: evaluation of its usefulness in routine clinical practice.

Authors:  N A Boyd; A R Bradwell; R A Thompson
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

6.  Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes.

Authors:  S Bhakdi; R Käflein; T S Halstensen; F Hugo; K T Preissner; T E Mollnes
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

7.  Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue.

Authors:  J T Reilly; J R Nash
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

8.  Effects of fibronectin-related peptides on cell spreading.

Authors:  J E Silnutzer; D W Barnes
Journal:  In Vitro Cell Dev Biol       Date:  1985-01

9.  A mechanism for assembly of complexes of vitronectin and plasminogen activator inhibitor-1 from sedimentation velocity analysis.

Authors:  Kenneth H Minor; Christine R Schar; Grant E Blouse; Joseph D Shore; Daniel A Lawrence; Peter Schuck; Cynthia B Peterson
Journal:  J Biol Chem       Date:  2005-05-19       Impact factor: 5.157

10.  Bone is not essential for osteoclast activation.

Authors:  Karen Fuller; Jade L Ross; Kinga A Szewczyk; Raymond Moss; Tim J Chambers
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.